A Dynamic Reinfection Hypothesis of Latent Tuberculosis Infection
- P.-J. Cardona
- … show all 1 hide
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
It has been traditionally postulated that individuals, once infected by Mycobacterium tuberculosis, will retain throughout their entire lifetime latent bacilli which will remain dormant in old lesions. This bacillus would then be the source of a later reactivation of active tuberculosis (TB), with the aid of resuscitation factors. Unfortunately, the presence of these bacilli can only be predicted by indirect immunological methods, such as the tuberculin skin test (TST) or T cell interferon–gamma release assays. Other evidence shows that a 9-month isoniazid treatment of TST+ individuals converting to TB reduces the incidence of TB by approximately 90%.
Taking into account this widely accepted framework, I suggest that there are at least three relevant questions to answer: (1) How can dormant bacilli remain in the lungs for an entire lifetime, taking into account constant cellular turnover and the healing of damaged tissues? (2) What provides the resuscitation factor to dormant bacilli, assuming that these latent bacilli are indeed present inside old lesions? (3) Why can a 9-month treatment with isoniazid eliminate dormant bacilli? As isoniazid is active only against growing bacilli, and thus is only able to destroy them after reactivation of latent bacilli, this treatment should have to be provided for life if the traditionally accepted postulate is correct.
For a better understanding of latent TB infection. I propose a hypothesis that describes a dynamic scenario of constant endogenous reinfection with M. tuberculosis which explains the efficacy of the current standard of treatment. If this hypothesis is true, new strategies for the management of TB may arise.
- Rieder HL: Epidemiologyic basis of Tuberculosis. International Union against Tuberculosis and Lung Diseases, Paris 1999.
- Rothel JS, Andersen P: Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 2005; 3: 981–993. CrossRef
- Orme M: The latent tuberculosis bacillus (I’ll let you know if I ever meet one). Int J Tuberc Lung Dis 2001; 5: 589–593.
- Comstock GW: How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999; 3: 847–850.
- Ulrichs T, Kaufmann SH: New insights into the function of granulomas in human tuberculosis. J Pathol 2006; 208: 261–269. CrossRef
- Park MK, Myers RA, Marzella L: Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis 1992; 14: 720–740.
- Harmon KR, Marinelli WA, Henke CA, Bitterman PB: Regulation of cell replication. In: Crystal RG, West JB, (eds): The lung: scientific foundations, vol 2.9. Raven Press Ltd, New York 1991, pp 105–129.
- Howat WJ, Holgate ST, Lackie PM: TGF-beta isoform release and activation during in vitro bronchial epithelial wound repair. Am J Physiol Lung Cell Mol Physiol 2002; 282: L115–L123.
- Daniel TM: The history of tuberculosis. Respir Med 2006; 100: 1862–1870. CrossRef
- Hernandez-Pando R, Jeyanathan M, Mengistu G, et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000; 356: 2133–2138. CrossRef
- Opie EL, Aronson JD: Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol 1927; 4: 121.
- Shleeva MO, Bagramyan K, Telkov MV, et al. Formation and resuscitation of “non-culturable” cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase. Microbiology 2002; 148: 1581–1591.
- Fox W, Ellard GA, Mitchison DA: Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3: S231–S279.
- Cardona PJ, Llatjós R, Gordillo S, Díaz J, Ojanguren I, Ariza A, Ausina V: Evolution of granulomas in mice infected aerogenically with Mycobacterium tuberculosis. Scand J Immunol 2000; 52: 156–163. CrossRef
- Cardona PJ, Gordillo S, Díaz J, Tapia G, Amat I, Pallarés A, Vilaplana C, Ariza A, Ausina V: Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect Immun 2003; 71: 5845–5854. CrossRef
- Dvorak AM, Dvorak HF, Peters SP, Shulman ES, MacGlashan DWJr, Pyne K, et al. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J Immunol 1983; 131: 2965–2976.
- D’Avila H, Melo RC, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT: Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J Immunol 2006; 176: 3087–3097.
- Muñoz-Elias EJ, Timm J, Botha T, Chan WT, Gomez JE, McKinney JD: Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect Immun 2005; 73: 546–551. CrossRef
- Wallace JG: The heat resistance of tubercle bacilli in the lungs of infected mice. Am Rev Respir Dis 1961; 83: 866–871.
- Morita RY: Bioavailability of energy and the starvation state. In: Kjelleberg S (ed): Starvation in bacteria, vol. Plenum Press, New York, 1993, pp 1–23.
- Cox RA: Quantitative relationships for specific growth rates and macromolecular compositions of Mycobacterium tuberculosis, Streptomyces coelicolor A3(2) and Escherichia coli B/r: an integrative theoretical approach. Microbiology 2004; 150: 142–3. CrossRef
- Mestas J, Hughes CC: Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172: 2731–2738.
- Hofmann W, Asgharian B: The effect of lung structure on mucociliary clearance and particle retention in human and rat lungs. Toxicol Sci 2003; 73: 448–456. CrossRef
- Bui TD, Dabdub D, George SC: Modeling bronchial circulation with application to soluble gas exchange: description and sensitivity analysis. J Appl Physiol 1998; 84: 2070–2088.
- Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444–449. CrossRef
- Caceres N, Tapia G, Ojanguren I, Ariza A, Ausina V, Cardona PJ: Evolution of foamy macrophages in the granuloma structure of the lungs in the murine Mycobacterium tuberculosis experimental model of aerosol infection. Importance of chemotherapy in the foamy macrophage clearance. Keystone Symposia. Vancouver, pp 20–25. March 2007, Poster no. 218, p 25.
- Hall-Stoodley L, Watts G, Crowther JE, Balagopal A, Torrelles JB, Robison-Cox J, et al. Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions. Infect Immun 2006; 74: 3587–3596. CrossRef
- Ko G, First MW, Burge HA: Influence of relativehumidity on particle size and UV sensitivity of Serratiamarcescens and Mycobacterium bovis BCG aerosols. Tuber Lung Dis 2000; 80: 217–228. CrossRef
- Lurie MB. Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms. Harvard University Press, Cambridge 1964.
- Doenhoff MJ: Granulomatous inflammation and the transmission of infection: schistosomiasis-and TB too? Immunol Today 1998; 19: 462–467. CrossRef
- Shaw JB, Wynn-Williams N: Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954; 69: 724–732.
- Garton NJ, Christensen H, Minnikin DE, Adegbola RA, Barer MR: Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology 2002; 148: 2951–2958.
- Murphy DJ: The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog Lipid Res 2001; 40: 325–438. CrossRef
- Neyrolles O, Hernández-Pando R, Pietri-Rouxel F, Fornes P, Tailleux L, Barris Payan JA, Pivert E, Bordat Y, Aguilar D, Prévost M-C, Petit C, Gicquel B: Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One 2006; 1: 1–9. CrossRef
- Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE 3rd: The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 2007; 189: 2583–2589. CrossRef
- Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, et al. Inhaling to mitigate exhaled bioaerosols. Proc Natl Acad Sci USA 2004; 101: 17383–17388. CrossRef
- Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, Supply P, Vincent V: Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLOS Pathol 2005; 1: 55–60.
- Andersen P: Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 1997; 45: 115–131. CrossRef
- Gordillo S, Guirado E, Gil O, Díaz J, Tapia G, Molinos S, Ausina V, Cardona PJ: Genetic expression of Mycobacterium tuberculosis under stressing conditions in “in vitro” and “in vivo” experimental models. Scand J Immunol 2006; 64: 30–39. CrossRef
- Andersen P, Doherty TM, Pai M, Weldingh K: The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 2007; 13: 175–182. CrossRef
- Hoff ST, Abebe M, Ravn P, Range N, Malenganisho W, Rodriques DS, et al. Evaluation of Mycobacterium tuberculosis-specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark. Clin Infect Dis 2007; 45: 575–582. CrossRef
- Glatman-Freedman A: Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy. FEMS Immunol Med Microbiol 2003; 39: 9–16. CrossRef
- Sanchez-Rodriguez C, Estrada-Chavez C, Garcia-Vigil J, et al. An IgG antibody response to the antigen 85 complex is associated with good outcome in Mexican Totonaca Indians with pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 6: 706–712.
- Guirado E, Amat I, Gil O, Díaz J, Arcos V, Caceres N, Ausina V, Cardona PJ: Passive serum-therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice. Microbes Infect 2006; 8: 1252–1259. CrossRef
- North RJ, Jung YJ: Immunity to tuberculosis. Annu Rev Immunol 2004; 22: 599–623. CrossRef
- Boros DL: The cellular immunological aspects of the granulomatous response. Granulomatous infections and inflammations. In: Boros DL (ed) Cellular and molecular mechanisms, vol 1. ASM Press, Washington D.C., 2003, pp 1–28.
- Cardona PJ, Ruiz-Manzano J: On the nature of Mycobacterium tuberculosis-latent bacilli. Eur Respir J 2004; 24: 1044–1051. CrossRef
- World Health Organization. TB/VIH. A clinical manual. Report no. WHO/HTM/TB/2004.329. WHO, Geneva 2004.
- Peyron P, Vaubourgeix J, Poquet Y, Botanch C, Levillain F, Bardou F, Daffe M, Emile JF, Cardona PJ, de Chastellier C, Altare F: Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathogens 2008; 4(11)e 1000204. CrossRef
- Cepelak I, Dodig S: Exhaled breath condensate: a new method for lung disease diagnosis. Clin Chem Lab Med 2007; 45: 945–952. CrossRef
- Gormus BJ, Blanchard JL, Alvarez XH, Didier PJ: Evidence for a rhesus monkey model of asymptomatic tuberculosis. J Med Primatol 2004; 33: 134–145. CrossRef
- Bolin CA, Whipple DL, Khanna KV, Risdahl JM, Peterson PK, Molitor TW: Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J Infect Dis 1997; 176: 1559–1566. CrossRef
- Gil O, Díaz I, Vilaplana C, Guirado E, Caceres N, Domingo M, Corner LAL, Cardona PJ: Therapeutic effect of the RUTI inoculation against the latent tuberculous infection. new insights crosswise the minipig experimental model. 7th International Conference of Pathogenesis of Mycobacterial Infections, 26–29 June 2008. Saltsjöbaden, Stockholm.
- Balasubramanian V, Wiegeshaus EH, Taylor BT, Smith DW: Pathogenesis of tuberculosis: pathway to apical localization. Tuber Lung Dis 1994; 75: 168–178. CrossRef
- Grange JM: Immunophysiology and immunopathology of tuberculosis. In: Davies PDO (ed): Clinical tuberculosis, vol 8. Chapman & Hall, London 1998, pp 113–127.
- Nardell E, McInnis B, Thomas B, Weidhaas S: Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med 1986; 315: 1570–1575.
- A Dynamic Reinfection Hypothesis of Latent Tuberculosis Infection
Volume 37, Issue 2 , pp 80-86
- Cover Date
- Print ISSN
- Online ISSN
- Urban and Vogel
- Additional Links
- Industry Sectors
- P.-J. Cardona (1) (2)
- Author Affiliations
- 1. Dept. of Microbiology, Experimental Tuberculosis Unit, Germans Trias I Pujol Health Science Research Institute Foundation, Autonomous University of Barcelona, Crta del Canyet s/n, Edifici Recerca, Badalona, Catalonia, Spain
- 2. CibeRES Biomedical Research Centre for Respiratory Diseases, Madrid, Spain